Topic - FDA

In a study of 469 adults comparing Zepbound users to patients who took a placebo, the Zepbound patients showed “a statistically significant and clinically meaningful reduction in events of apnea,” compared to the other group, the FDA said.

Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea →

Even water can now be labeled as healthy, the agency said.

FDA updates the definition of 'healthy' foods →